“Correlation Analysis of DNA UGT1A1 Gene Expression in Hyperbilirubinemia and Central Nervous System-Related Adverse Reactions Following Oral Dolutegravir Administration” (2023) Medinformatics, 1(1), pp. 35–42. doi:10.47852/bonviewMEDIN32021466.